Skip to content

13F-HR filed by HealthCor Management, L.P.

HealthCor Management, L.P. filed this 13F-HR for the quarter ended 2016-12-31, filed 2017-02-14, with 39 holding rows worth $1,769,574,000.

Accession
0001343781-17-000002
Filed
2017-02-14
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q4 2016

A holdings report, 39 entries on the cover page, a total value of $1,769,574,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $1,769,574,000 with VALUE read as thousands by filing date, 13F file number 028-11790. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
CELGENE CORP151020104COM1,500,000$173,625,000thousands by filing date
LABORATORY CORP OF AMERICA50540R409COM NEW1,150,000$147,637,000thousands by filing date
Intuitive Surgical,Inc.46120E602COM175,000$110,980,000thousands by filing date
AETNA INC NEW00817Y108COM839,030$104,048,000thousands by filing date
QUEST DIAGNOSTICS INC COM74834L100Stock1,125,000$103,388,000thousands by filing date
QIAGEN NVN72482107COMMON STOCK-FO2,850,000$79,857,000thousands by filing date
Danaher Corporation235851102COM1,004,650$78,202,000thousands by filing date
INCYTE CORP COM45337C102Stock741,360$74,336,000thousands by filing date
ZIMMER BIOMET HOLDINGS INC COM98956P102Stock674,760$69,635,000thousands by filing date
VCA ANTECH INC918194101COM1,000,000$68,650,000thousands by filing date
UnitedHealth Group Inc91324P102COM407,580$65,229,000thousands by filing date
BIOMARIN PHARMACEUTICAL INC09061G101COM775,000$64,201,000thousands by filing date
INC RESH HLDGS INC45329R109CL A1,123,920$59,118,000thousands by filing date
CIGNA CORPORATION125509109COM430,140$57,376,000thousands by filing date
PACIRA BIOSCIENCES INC COM695127100Stock1,575,000$50,873,000thousands by filing date
HAEMONETICS CORP MASS COM405024100Stock1,150,000$46,230,000thousands by filing date
HEALTHSOUTH CORP421924309COM NEW1,000,524$41,262,000thousands by filing date
NEUROCRINE BIOSCIENCES INC64125C109COM988,900$38,270,000thousands by filing date
Merck & Co.,Inc.58933Y105COM567,470$33,407,000thousands by filing date
ALEXION PHARMACEUTICALS INC015351109COM261,140$31,950,000thousands by filing date
CLOVIS ONCOLOGY INC189464100COM625,000$27,763,000thousands by filing date
Gilead Sciences,Inc.375558103COM350,000$25,064,000thousands by filing datecall
BARD C R INC067383109COM107,370$24,122,000thousands by filing date
DEXCOM INC COM252131107Stock378,650$22,605,000thousands by filing date
COLLEGIUM PHARMACEUTICAL INC19459J104COM1,426,300$22,207,000thousands by filing date
HOLOGIC INC436440101COM452,340$18,148,000thousands by filing date
PRA HEALTH SCIENCES INC69354M108COM300,000$16,536,000thousands by filing date
MEDPACE HLDGS INC COM58506Q109Stock425,000$15,330,000thousands by filing date
CORINDUS VASCULAR ROBOTICS I218730109COM19,981,655$13,955,000thousands by filing date
Thermo Fisher Scientific Inc.883556102COM94,980$13,402,000thousands by filing date
MONSANTO CO NEW61166W101COM125,000$13,151,000thousands by filing date
BAXTER INTL INC071813109COM293,650$13,020,000thousands by filing date
HCA Healthcare Inc40412C101COM157,260$11,640,000thousands by filing date
GLOBUS MED INC CL A379577208Stock450,000$11,165,000thousands by filing date
ALIGN TECHNOLOGY INC COM016255101Stock102,263$9,831,000thousands by filing date
SEASPINE HLDGS CORP81255T108COM641,700$5,069,000thousands by filing date
NATERA INC COM632307104Stock299,300$3,505,000thousands by filing date
AMICUS THERAPEUTICS INC03152W109COM500,000$2,485,000thousands by filing datecall
REVVITY INC714046109COM44,150$2,302,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001343781-17-000002this filing2017-02-14acceptance time not in the bulk data set